Neogenomics Inc (NEO)
Health Services • Health Care
Percentage
Change
| Apr 09 | Mar 10 | Feb 11 | Mar 12 | Feb 13 | Feb 14 | Mar 15 | Mar 16 | Mar 17 | Mar 18 | Feb 19 | Feb 20 | Feb 21 | Feb 22 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income to Common | -79 | -108 | ||||||||||||||||
Net Income | -79 | -108 | ||||||||||||||||
Profit | -79 | -108 | ||||||||||||||||
Net Income Continuing | -79 | -108 | ||||||||||||||||
Income Tax Expense | 2 | 2 | ||||||||||||||||
Pretax Income | -81 | -110 | ||||||||||||||||
Total Non-operating Income | 11 | 6 | ||||||||||||||||
Operating Income | -92 | -116 | ||||||||||||||||
Total Revenue | 661 | 727 | ||||||||||||||||
Total Costs and Expenses | -753 | -843 | ||||||||||||||||
Cost of Revenue | -370 | -413 | ||||||||||||||||
Operating Expenses | -382 | -430 | ||||||||||||||||
Impairment Expense | 0 | -28 | ||||||||||||||||
Research and Development Expenses | -31 | -37 | ||||||||||||||||
Selling, General & Administrative Expenses | -344 | -365 | ||||||||||||||||
Other Operating Expenses | -7 | 0 |